Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Alder Biopharma (ALDR)

Alder Biopharma (ALDR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,582,842
  • Shares Outstanding, K 83,837
  • Annual Sales, $ 0 K
  • Annual Income, $ -296,430 K
  • 60-Month Beta 2.64
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 14.29
Trade ALDR with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -3.54
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 11/04/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.78
  • Number of Estimates 4
  • High Estimate -0.60
  • Low Estimate -1.00
  • Prior Year -0.91
  • Growth Rate Est. (year over year) +14.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.60 +1.51%
on 09/23/19
19.12 -1.26%
on 10/21/19
+0.24 (+1.29%)
since 09/20/19
3-Month
8.39 +125.03%
on 09/09/19
19.12 -1.26%
on 10/21/19
+9.06 (+92.26%)
since 07/19/19
52-Week
8.39 +125.03%
on 09/09/19
19.12 -1.26%
on 10/21/19
+6.29 (+49.96%)
since 10/19/18

Most Recent Stories

More News
Lengo Therapeutics Announces Expansion of its Executive Leadership Team with Appointments in R&D, CMC and Finance

Lengo Therapeutics, a biopharmaceutical company developing novel precision medicines targeting driver mutations in oncology, today announced the expansion of the Company’s executive management team.

ALDR : 18.88 (-0.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Alder Biopharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It discovers, develops and seeks to commercialize therapeutic antibodies. It is developing monoclonal antibodies comprising ALD403, for the prevention of migraine; and Clazakizumab, in the treatment of rheumatoid arthritis and...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 19.24
1st Resistance Point 19.06
Last Price 18.88
1st Support Level 18.76
2nd Support Level 18.65
3rd Support Level N/A

See More

52-Week High 19.12
Last Price 18.88
Fibonacci 61.8% 15.02
Fibonacci 50% 13.76
Fibonacci 38.2% 12.49
52-Week Low 8.39

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar